Function and disability in children with Costello syndrome and Cardiofaciocutaneous syndrome

Barbara Johnson1, Dina Goldberg-Strassler, Karen Gripp

  • 1Physical Therapy Program, University of Wisconsin, LaCrosse, Wisconsin.

Insights

Costello syndrome (CS) and Cardiofaciocutaneous syndrome (CFCS) present similar functional limitations and disability severity in children. Both RASopathies show significant differences from normative values, impacting mobility, social interaction, and daily activities.

Area of Science:

  • Genetics and Developmental Biology
  • Pediatric Medicine
  • Rehabilitation Sciences

Background:

  • RASopathies are a group of genetic disorders with limited research on functional outcomes.
  • Costello syndrome (CS) and Cardiofaciocutaneous syndrome (CFCS) are distinct RASopathies with overlapping features.
  • Understanding functional performance and disability is crucial for comprehensive care in these conditions.

Purpose of the Study:

  • To compare the functional performance and disability levels between children with CS and CFCS.
  • To identify specific areas of functional limitation and disability in these pediatric populations.
  • To establish a baseline for future research and clinical interventions.

Main Methods:

  • Utilized the Pediatric Outcomes Data Collection Instrument (PODCI) and Pediatric Evaluation of Disability Index (PEDI) questionnaires.
  • Collected data from parents of children diagnosed with CS and CFCS.
  • Compared scores between the CS and CFCS groups and with published normative data.

Main Results:

  • No significant differences were found in PODCI or PEDI scores between the CS and CFCS groups.
  • Both groups exhibited statistically significant functional limitations compared to normative data across multiple domains.
  • Significant impairments were noted in mobility, social interaction, and daily activities for both CS and CFCS patients.

Conclusions:

  • Costello syndrome and Cardiofaciocutaneous syndrome demonstrate comparable functional limitations and disability severity.
  • Children with CS and CFCS experience substantial challenges in upper extremity function, transfers, mobility, and physical activities.
  • These findings highlight the need for targeted support and interventions to address the functional deficits in individuals with CS and CFCS.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
93.0K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
645
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789